Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer. (Q34989774)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer. |
scientific article |
Statements
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer (English)
Martin J Schlumberger
Lori J Wirth
Renato G Martins
Furio Pacini
Chantal Daumerie
Jean-Pierre Droz
Michael J Eschenberg
Yu-Nien Sun
Todd Juan
Daniel E Stepan